Ombre

Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing. The company's microbiome testing kit offers subscription-based customized testing of the microbiome with a personalized probiotic created specifically for the individual to get actionable insights into the prevention of chronic diseases including obesity, cystic fibrosis, and Alzheimer's, enabling customers to treat root causes of gut problems.

Ombre headquartered in United States, North America, operates in the Health Care, Wellness, Dietary Supplements sector. The company focuses on Health Care and has secured $504.0M in funding across 60 round(s). With a team of 1-10 employees, Ombre is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Ombre, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.